Tarsus Pharmaceuticals (TARS) Times Interest Earned (2022 - 2025)
Historic Times Interest Earned for Tarsus Pharmaceuticals (TARS) over the last 4 years, with Q3 2025 value amounting to -$6.41.
- Tarsus Pharmaceuticals' Times Interest Earned rose 3775.19% to -$6.41 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.68, marking a year-over-year increase of 5508.24%. This contributed to the annual value of -$15.36 for FY2024, which is 6409.69% up from last year.
- According to the latest figures from Q3 2025, Tarsus Pharmaceuticals' Times Interest Earned is -$6.41, which was up 3775.19% from -$9.9 recorded in Q2 2025.
- Tarsus Pharmaceuticals' Times Interest Earned's 5-year high stood at -$6.41 during Q3 2025, with a 5-year trough of -$61.78 in Q1 2022.
- Its 4-year average for Times Interest Earned is -$26.79, with a median of -$21.76 in 2022.
- As far as peak fluctuations go, Tarsus Pharmaceuticals' Times Interest Earned crashed by 31936.28% in 2023, and later skyrocketed by 7842.96% in 2024.
- Quarter analysis of 4 years shows Tarsus Pharmaceuticals' Times Interest Earned stood at -$21.76 in 2022, then tumbled by 106.5% to -$44.94 in 2023, then soared by 76.5% to -$10.56 in 2024, then skyrocketed by 39.35% to -$6.41 in 2025.
- Its Times Interest Earned stands at -$6.41 for Q3 2025, versus -$9.9 for Q2 2025 and -$11.88 for Q1 2025.